Autoimmune thrombocytopenic purpura

MONDO:0008558

An autoimmune disorder in which the number of circulating platelets is reduced due to their antibody-mediated destruction. ITP is a diagnosis of exclusion and is heterogeneous in origin.

Also known as: immune thrombocytopenia, ITP, autoimmune thrombocytopenic purpura, idiopathic thrombocytopenia, idiopathic thrombocytopenia purpura, idiopathic thrombocytopenic purpura, thrombocytopenic purpura, autoimmune, AITP

142 clinical trials for this condition and its sub-types, 95 tagged with Autoimmune thrombocytopenic purpura itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Thrombocytopenic purpura (116) ↑ Autoimmune thrombocytopenia (113) ↑ Primary thrombocytopenia (110)

Including sub-types (142) Tagged with Autoimmune thrombocytopenic purpura (95)

Trials to join now! 45 Not yet recruiting 25 Not yet finished but already full! 8 Completed 16 Terminated 1

Experimental drug iptacopan tested for rare blood disorders

Disease control Stopped early

This study tested an experimental drug called iptacopan in people with two rare blood disorders: immune thrombocytopenia (ITP) and cold agglutinin disease (CAD). The goal was to see if the drug could improve platelet counts in ITP or hemoglobin levels in CAD. The trial was termin…

Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

Autoimmune thrombocytopenic purpura

Where it sits in the disease tree

Experimental drug iptacopan tested for rare blood disorders